A closer look at the science, the companies, and what comes next.
This is a research snapshot of 110 companies and 566 pipeline/indication entries, compiled September 18, 2026. Company pages bring together pipeline biology, the latest retrieved transcripts, trial events and local Chiron research.
Transcript coverage: 92 companies have three reviewed transcripts. The other 18 have fewer, with gaps labeled on their pages. Events include earnings calls, conferences and study-result presentations. These are the latest events retrieved from the searched archives, not a guarantee that every latest event was transcribed.
Readouts: expected data releases are shown separately from trial starts, filings and regulatory decisions. Timing is company guidance, not a guaranteed release date. Registry completion dates are not treated as publication dates. The readout view uses the September 18 snapshot, not a live calendar.
Biology & ownership: pathway inferences are labeled. Historical, discontinued and spun-out programs remain in the research and can be hidden in each pipeline. Source links open the original material; Chiron local archives are identified but are not hosted here.
Your saved companies stay in this browser. The CSV download contains the full collection, regardless of filters.
Please enable JavaScript to explore the company directory and download the research.